![]()
|
|
||||||||
J Biol Chem, Vol. 273, Issue 47, 31103-31107, November 20, 1998
,
From the The antimalarial quinolines are believed to work
by blocking the polymerization of toxic heme released during hemoglobin
proteolysis in intraerythrocytic Plasmodium falciparum. In
the presence of free heme, chloroquine and quinidine associate with the
heme polymer. We have proposed that this association of the
quinoline-heme complex with polymer caps the growing heme polymer,
preventing further sequestration of additional heme that then
accumulates to levels that kill the parasite. In this work results of
binding assays demonstrate that the association of quinoline-heme
complex with heme polymer is specific, saturable, and high affinity and
that diverse quinoline analogs can compete for binding. The relative quinoline binding affinity for heme polymer rather than free heme correlates with disruption of heme polymerization. Mefloquine, another
important antimalarial quinoline, associated with polymer in a similar
fashion, both in cultured parasites and in the test tube. In parasite
culture, blocking heme release with protease inhibitor was antagonistic
to mefloquine action, as it is to chloroquine action. These data
suggest a common mechanism for quinoline antimalarial action dependent
on drug interaction with both heme and heme polymer.
Department of Molecular Microbiology and
Immunology, Johns Hopkins School of Hygiene and Public Health,
Baltimore, Maryland 21205, ¶ Hoffmann-La Roche, Pharmaceuticals
Division, Pharma Research Preclinical, Basel, Switzerland, CH-4070 and
Howard Hughes Medical Institute, Departments of Medicine and
Molecular Microbiology, Washington University School of Medicine,
St. Louis, Missouri 63110
This article has been cited by other articles:
![]() |
R. Hayward, K. J. Saliba, and K. Kirk The pH of the digestive vacuole of Plasmodium falciparum is not associated with chloroquine resistance J. Cell Sci., March 15, 2006; 119(6): 1016 - 1025. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Hayward, K. J. Saliba, and K. Kirk Mutations in pfmdr1 Modulate the Sensitivity of Plasmodium falciparum to the Intrinsic Antiplasmodial Activity of Verapamil Antimicrob. Agents Chemother., February 1, 2005; 49(2): 840 - 842. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. C. Hoppe, D. A. van Schalkwyk, U. I. M. Wiehart, S. A. Meredith, J. Egan, and B. W. Weber Antimalarial Quinolines and Artemisinin Inhibit Endocytosis in Plasmodium falciparum Antimicrob. Agents Chemother., July 1, 2004; 48(7): 2370 - 2378. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Lopez-Estrano, S. Bhattacharjee, T. Harrison, and K. Haldar Cooperative domains define a unique host cell-targeting signal in Plasmodium falciparum-infected erythrocytes PNAS, October 14, 2003; 100(21): 12402 - 12407. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. B. S. Sidhu, D. Verdier-Pinard, and D. A. Fidock Chloroquine Resistance in Plasmodium falciparum Malaria Parasites Conferred by pfcrt Mutations Science, October 4, 2002; 298(5591): 210 - 213. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Dzierszinski, A. Coppin, M. Mortuaire, E. Dewailly, C. Slomianny, J.-C. Ameisen, F. DeBels, and S. Tomavo Ligands of the Peripheral Benzodiazepine Receptor Are Potent Inhibitors of Plasmodium falciparum and Toxoplasma gondii In Vitro Antimicrob. Agents Chemother., October 1, 2002; 46(10): 3197 - 3207. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. A. Cooper, M. T. Ferdig, X.-Z. Su, L. M. B. Ursos, J. Mu, T. Nomura, H. Fujioka, D. A. Fidock, P. D. Roepe, and T. E. Wellems Alternative Mutations at Position 76 of the Vacuolar Transmembrane Protein PfCRT Are Associated with Chloroquine Resistance and Unique Stereospecific Quinine and Quinidine Responses in Plasmodium falciparum Mol. Pharmacol., January 1, 2002; 61(1): 35 - 42. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Kurosawa, A. Dorn, M. Kitsuji-Shirane, H. Shimada, T. Satoh, H. Matile, W. Hofheinz, R. Masciadri, M. Kansy, and R. G. Ridley Hematin Polymerization Assay as a High-Throughput Screen for Identification of New Antimalarial Pharmacophores Antimicrob. Agents Chemother., October 1, 2000; 44(10): 2638 - 2644. [Abstract] [Full Text] |
||||
![]() |
T. Akompong, N. Ghori, and K. Haldar In Vitro Activity of Riboflavin against the Human Malaria Parasite Plasmodium falciparum Antimicrob. Agents Chemother., January 1, 2000; 44(1): 88 - 96. [Abstract] [Full Text] |
||||
![]() |
A. V. Pandey, B. L. Tekwani, R. L. Singh, and V. S. Chauhan Artemisinin, an Endoperoxide Antimalarial, Disrupts the Hemoglobin Catabolism and Heme Detoxification Systems in Malarial Parasite J. Biol. Chem., July 2, 1999; 274(27): 19383 - 19388. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |